Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| aggressive cancer prostate |
|
Research Links Gene to Aggressive Prostate Cancer For each sixpeat, they found a 70 percent decrease in the likelihood of aggressive prostate cancer. On the other hand, men with six fewer repeats were twice TGen finds key prostate cancer gene Scientists from TGen and other research facilities and universities have identified a gene that may be linked to an aggressive form of prostate cancer, Frequent Prostate Screens Fail to Improve Aggressive Cancer TUESDAY, Aug. 28 (HealthDay News) -- Being screened for prostate cancer more often does improve disease detection overall, but it doesn't help doctors spot Study finds gene linked to aggressive prostate cancer Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive Grading | Prostate Cancer Information | UPMC Cancer Centers The more closely the cancer cells resemble prostate tissue, the more the cells will behave like normal prostate tissue and the less aggressive the cancer. MedlinePlus: Gene Variant Tied to More Aggressive Prostate Cancer Gene Variant Tied to More Aggressive Prostate Cancer. Genetic marker linked to aggressive prostate cancer PhysOrg news: Genetic marker linked to aggressive prostate cancer. BBC NEWS | Health | Fish oils 'block prostate cancer' A diet rich in a fat found in oily fish and some seeds may protect men with prostate cancer from developing a more aggressive form, scientists have found. BRCA2 Mutation Linked to Aggressive Prostate Cancer - Prostate Data from the Icelandic Cancer Registry report that a specific BRCA2 gene mutation is strongly predictive of aggressive prostate cancer and greatly Improvement in Survival for Aggressive Prostate Cancer - Prostate Decisive treatment of aggressive prostate cancers that haven't yet spread to other sites in the body can lead to a significant improvement in survival Prostate cancer - CNN.com Some forms of prostate cancer are aggressive and can spread quickly to other parts of your body. What causes prostate cancer and why some types behave ACS :: Rapid Rise in PSA May Predict Aggressive Prostate Cancer How quickly a man's PSA level has been rising before a diagnosis of prostate cancer may help doctors predict whether the cancer is more likely to kill him, Aggressive Prostate Cancer aggressive prostate cancer requires aggressive prostate cancer treatment. Prostate Cancer - CancerConsultants.com Prostate cancer can be relatively harmless or extremely aggressive. Some prostate cancers are slow growing, causing few clinical symptoms. Early Hormone Therapy Best for Men with Aggressive Prostate Cancer "Evidence shows that if you have very aggressive prostate cancer that could kill you, early hormone therapy is your best bet."" Obesity Is Risk Factor For Aggressive Prostate Cancer Obesity appears to increase the risk of prostate cancer, particularly aggressive disease, and may make it harder to find, researchers say. Genetic Marker Linked To Aggressive Prostate Cancer A recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease, according to new research. Primer on prostate cancer (Pogliano) CGA testing measures the blood levels of Chromogranin A. This test is used to help identify patients with an aggressive form of prostate cancer and to help Prostate Cancer: What You Need to Know -- familydoctor.org Like many types of cancer, prostate cancer can be aggressive. This means it grows quickly and can spread to other parts of the body. (When cancer spreads |
| aggressive cancer prostate |
|
antiprostate cum gland prostate stimulate antigen normal prostate specific test enlarge prostate agent orange |